STOCK TITAN

Johnson & Johnson legal chief sells 13,072 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Johnson & Johnson EVP, Chief Legal Officer Elizabeth Forminard exercised options for 13,072 common shares at $151.41 per share on November 12, 2026, then sold 13,072 shares at $284.39 per share that day. No Rule 10b5-1 plan is reported.

Insider Forminard Elizabeth
Role EVP, Chief Legal Officer
Sold 13,072 shs ($3.72M)
Approx. gross sale proceeds $3.72M
Approx. exercise cost $1.98M
Approx. pre-tax spread $1.74M
Share of Position Sold 43.5%
Type Security Shares Price Value
Exercise Employee Stock Options (Right to Buy) F1 13,072 $0.00 $0.00
Exercise Common Stock 13,072 $151.41 $1.98M
Sale Common Stock 13,072 $284.39 $3.72M
Holdings After Transaction: Employee Stock Options (Right to Buy) — 0 options (Direct); Common Stock — 16,994 shares (Direct)
Holdings Before and After: Employee Stock Options (Right to Buy), 13,072 to 0 options (Direct); Common Stock, 16,994 to 16,994 shares (Direct)
Footnotes (1)
  1. F1. Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.
Options exercised 13,072 options November 12, 2026
Exercise price $151.41 per share Options exercised November 12, 2026
Shares sold 13,072 shares November 12, 2026
Sale price $284.39 per share Shares sold November 12, 2026
Long-Term Incentive Plan financial
"Awarded under Issuer's Long-Term Incentive Plan."
A long-term incentive plan is a company program that pays executives or employees with stock, options, or cash tied to multi-year performance goals, where the rewards become theirs only after meeting conditions over time. Think of it as a delayed bonus or retirement-style reward that aligns employees’ interests with shareholders by encouraging them to boost long-term value; investors watch these plans because they affect pay costs, share dilution and management incentives.
Stock Option Award financial
"The Stock Option Award vests and is exercisable"
A stock option award is a grant that gives an employee the right to buy a company’s shares at a fixed price for a limited time, often becoming available gradually over a set schedule. Investors care because these awards align workers’ incentives with company performance, can increase employee loyalty, and may create future share dilution and compensation expense that affect earnings per share and shareholder value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many JNJ shares did Elizabeth Forminard sell, and at what price?

Elizabeth Forminard sold 13,072 JNJ shares at $284.39 per share on November 12, 2026, after exercising options for 13,072 shares at $151.41 per share.

What are the vesting terms for Elizabeth Forminard’s JNJ stock options?

The options were awarded under Johnson & Johnson’s Long-Term Incentive Plan and vest and are exercisable on the third anniversary of the grant date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Forminard Elizabeth

(Last)(First)(Middle)
ONE JOHNSON & JOHNSON PLAZA

(Street)
NEW BRUNSWICK NEW JERSEY 08933

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
JOHNSON & JOHNSON [ JNJ ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP, Chief Legal Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/12/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/12/2026M13,072A$151.4130,066D
Common Stock11/12/2026S13,072D$284.3916,994D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Options (Right to Buy)$151.4111/12/2026M13,07202/10/2023(1)02/10/2030Common Stock13,072$00D
Explanation of Responses:
1. Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.
Remarks:
/s/ Joleen Morgan, as attorney-in-fact for Elizabeth Forminard11/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading